CORC  > 复旦大学上海医学院
Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine
Wang, Xiaoying/55969559500[0]; Zhao, Fengshu/12793778800[1]; He, Xiangfeng/35277232800[2]; Wang, Jing/56042374500[3]; Zhang, Ying/55613583979[4]; Zhang, Hongyi/45461531800[5]; Ni, Yaoyao/56659008100[6]; Sun, Jianan/56606445800[7]; Wang, Xiaobing/57192627005[8]; Dou, Jun/8852232200[9]
刊名Oncotarget
2015
卷号6期号:14
关键词Interleukin-21 Melanoma MiR200c Transforming growth factor β1 Tumor vaccine
ISSN号1949-2553
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4874691
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Wang, Xiaoying/55969559500[0],Zhao, Fengshu/12793778800[1],He, Xiangfeng/35277232800[2],et al. Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine[J]. Oncotarget,2015,6(14).
APA Wang, Xiaoying/55969559500[0].,Zhao, Fengshu/12793778800[1].,He, Xiangfeng/35277232800[2].,Wang, Jing/56042374500[3].,Zhang, Ying/55613583979[4].,...&Dou, Jun/8852232200[9].(2015).Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine.Oncotarget,6(14).
MLA Wang, Xiaoying/55969559500[0],et al."Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine".Oncotarget 6.14(2015).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace